SEC Company Response from Synergy CHC Corp. (SNYR) (CIK 0001562733) (SNYRQ) — Nov 9, 2016
Synergy CHC Corp. (SNYR) (CIK 0001562733)
Date: Nov. 9, 2016 · CIK: 0001562733 · Accession: 0001493152-16-014644
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-55098
Referenced dates: November 8, 2016
Letter
Wyrick Robbins Yates & Ponton LLP
ATTORNEYS AT LAW
Lake Boone Trail, Suite 300, Raleigh, NC 27607
PO Drawer 17803, Raleigh, NC 27619
P: 919.781.4000 F: 919.781.4865 www.wyrick.com
November 8, 2016
VIA EMAIL: PAIKI@SEC.GOV
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare and Insurance
F Street N.E.
Washington, DC 20549
Attention:
Ms. Suzanne Hayes
Ms. Irene Paik
Re:
Synergy CHC Corp.
Form 10-K for Fiscal Year Ended December 31, 2015
Filed March 30, 2016
File No. 000-55098
We write this letter on behalf of our client Synergy CHC Corp. (“Synergy”) in response to the comments of the Staff of the Securities and Exchange Commission with respect to the above-captioned 10-K, as set forth in the Staff’s letter dated November 8, 2016.
1. Synergy confirms that they will revise future results of operations disclosures, as applicable, to identify individual product acquisitions that have materially impacted results of operations for the fiscal year and quantify those amounts separately.
Thank you.
Wryrick Robbins Yates & Ponton LLP
Show Raw Text
CORRESP
1
filename1.htm
Wyrick
Robbins Yates & Ponton LLP
ATTORNEYS
AT LAW
4101
Lake Boone Trail, Suite 300, Raleigh, NC 27607
PO
Drawer 17803, Raleigh, NC 27619
P:
919.781.4000 F: 919.781.4865 www.wyrick.com
November
8, 2016
VIA
EMAIL: PAIKI@SEC.GOV
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Healthcare and Insurance
100
F Street N.E.
Washington,
DC 20549
Attention:
Ms.
Suzanne Hayes
Ms.
Irene Paik
Re:
Synergy
CHC Corp.
Form
10-K for Fiscal Year Ended December 31, 2015
Filed
March 30, 2016
File
No. 000-55098
We
write this letter on behalf of our client Synergy CHC Corp. (“Synergy”) in response to the comments of the Staff of
the Securities and Exchange Commission with respect to the above-captioned 10-K, as set forth in the Staff’s letter dated
November 8, 2016.
1.
Synergy confirms that they will revise future results of operations disclosures, as applicable, to identify individual product
acquisitions that have materially impacted results of operations for the fiscal year and quantify those amounts separately.
Thank
you.
Wryrick
Robbins Yates & Ponton LLP